Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer

NCT00139711

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Pfizer Investigational Site Alzano Lombardo, BG, Italy
  • Pfizer Investigational Site Gravedona, CO, Italy
  • Pfizer Investigational Site Crema, CR, Italy
  • Pfizer Investigational Site Gorgonzola, MI, Italy
View all 15 locations
View Trial Details
Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

NCT00278070

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Henry Dunant Hospital Athens, Greece
  • Sotiria Hospital Athens, Greece
  • University Hospital "Attikon" Athens, Greece
  • Agii Anargiri Cancer Hospital Athens, Greece
View Trial Details
Completed

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

NCT00051974

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • U of Alambama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Center Thoracic Malignancy Los Angeles, California, United States
  • University of Colorado Health Sciences Center Aurora, Colorado, United States
View all 20 locations
View Trial Details
Completed

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

NCT00095225

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations
  • Comprehensive Blood and Cancer Center (TORI) Bakersfield, California, United States
  • Bay Area Cancer Research Group Concord, California, United States
  • Virginia K. Crosson Cancer Center (TORI) Fullerton, California, United States
  • California Cancer Center, Inc Greenbrae, California, United States
View all 48 locations
View Trial Details
Completed

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00080340

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UAB CCC Clinical Studies Unit Birmingham, Alabama, United States
  • Department of Veterans Affairs Medical Center Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 338 locations
View Trial Details

Related conditions